Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov;27(11):2325-2327.
doi: 10.1002/ejhf.3789. Epub 2025 Jul 21.

Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure

Tibor Kempf  1   2 , Welf Geller  1 , Jan Fuge  3   4 , Mircea-Andrei Sandu  1   2 , Marius M Hoeper  3   4 , Roman Pfister  5 , Sascha Macherey-Meyer  5 , Stefan Störk  6 , Daniel Scheiber  7 , Jürgen Bogoviku  8 , Jörn Tongers  9 , Tarek Bekfani  10 , Christoph Schindler  11 , Dominik Berliner  1 , Udo Bavendiek  1 , Johann Bauersachs  1
Affiliations

Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure

Tibor Kempf et al. Eur J Heart Fail. 2025 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Box plots illustrating the temporal changes in haemoglobin levels (A), ferritin concentrations (B), and transferrin saturation (C) at baseline, 8 weeks, and 16 weeks in all patients from the primary analysis set (n = 41). Measurements from baseline to week 16 were compared using a paired t‐test.
See this image and copyright information in PMC

References

    1. Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Eur Heart J 2023;44:14–27. 10.1093/eurheartj/ehac569 - DOI - PMC - PubMed
    1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2024;26(1):5–17. 10.1002/ejhf.3024 - DOI - PubMed
    1. Anker SD, Karakas M, Mentz RJ, Ponikowski P, Butler J, Khan MS, et al. Systematic review and meta‐analysis of intravenous iron therapy for patients with heart failure and iron deficiency. Nat Med 2025;31:2640–2646. 10.1038/s41591-025-03671-1 - DOI - PMC - PubMed
    1. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al.; NHLBI Heart Failure Clinical Research Network . Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF randomized clinical trial. JAMA 2017;317:1958–1966. 10.1001/jama.2017.5427 - DOI - PMC - PubMed
    1. Karavidas A, Troganis E, Lazaros G, Balta D, Karavidas IN, Polyzogopoulou E, et al. Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: A non‐randomized, open‐label, proof‐of‐concept study. Eur J Heart Fail 2021;23:593–597. 10.1002/ejhf.2092 - DOI - PubMed